Announcements Trials
Browse Landscape

Status

No longer available 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 180Observational 25Expanded_access 3

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 2

Conditions

Gastrointestinal Stromal Tumors 2Colorectal Neoplasms 1

Interventions

regorafenib 3Sunitinib 2Ramucirumab 2Oxaliplatin 2Fluorouracil 2zenocutuzumab 1zanidatamab 1ulixertinib 1trifluridine tipiracil drug combination 1sodium thiosulfate 1selpercatinib 1ripretinib 1peginterferon alfa-2a 1pegilodecakin 1onvansertib 1omburtamab I-131 1guselkumab 1futibatinib 1derazantinib 1balstilimab 1avapritinib 1Tenofovir 1Taxes 1Proton Pump Inhibitors 1Paclitaxel 1Melphalan 1Leucovorin 1Laparoscopy 1Imatinib Mesylate 1IMM-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × regorafenib × Gastrointestinal × Clear all
NCT01538680 2019-05-29

CONSIGN

Bayer

No longer available
Gastrointestinal

Colorectal Neoplasms

NCT01689376 2016-08-16

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01646593 2014-12-15

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡